E14K (p.Glu14Lys) variant of PRKCB (Protein kinase C beta type)
E14K (p.Glu14Lys) in PRKCB (Protein kinase C beta type) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.68 / 1. The record also includes population frequency data and structural context.
E14K (p.Glu14Lys) variant details
- p.Glu14Lys
- rs771388864
- ExAC rs771388864
- gnomAD rs771388864
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.685
- CADD 23.00
- PolyPhen-2 0.00
- SIFT 0.21
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available